Advances in researches on long coronavirus disease in children: a narrative review

Jiaqian Zhang1, Taiji Kuang1, Xinglou Liu1

  • 1Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

PubMed

Insights

Long COVID in children, a significant post-COVID-19 condition, requires more research. This review summarizes current knowledge on pediatric long COVID to aid clinicians and researchers.

Area of Science:

  • Pediatric Infectious Diseases
  • Public Health
  • Clinical Research

Background:

  • Coronavirus disease 2019 (COVID-19) has led to millions of infections globally.
  • Key pediatric sequelae include multi-system inflammatory syndrome and long COVID.
  • Long COVID presents a higher incidence and broader impact in children compared to other conditions.

Purpose of the Study:

  • To consolidate current knowledge on long COVID in children.
  • To assist pediatricians and researchers in understanding and managing pediatric long COVID.
  • To guide future research and clinical treatment strategies.

Main Methods:

  • A comprehensive literature review was conducted.
  • Studies on "long COVID", pediatric, children, adolescent, and post-COVID syndrome were searched in PubMed.
  • Publications after 2019 were included.

Main Results:

  • The review synthesizes current research on the epidemiology, pathogenesis, and clinical features of pediatric long COVID.
  • Analysis of existing data provides insights into diagnostic approaches for COVID-19 in children.
  • Potential therapeutic interventions for long COVID in children are identified.

Conclusions:

  • This review offers a summary of existing research on pediatric long COVID.
  • Findings aim to support clinical diagnosis, treatment, and prevention efforts.
  • Provides a foundation for further molecular-level research into disease mechanisms.
Abstract

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...